Similarly, studies have demonstrated that suPAR binds to apolipoprotein L1 (ApoL1), a circulating protein whose genetic variants, G1 and G2, are associated with an increased risk of kidney disease in individuals of recent African descent (33, 81–87). Here, APOL1 is linked to kidney disorder.